Royce & Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.47M | Buy |
663,010
+92,130
| +16% | +$1.04M | 0.08% | 372 |
|
|
2025
Q1 | $5.41M | Sell |
570,880
-5,320
| -0.9% | -$50.4K | 0.06% | 432 |
|
|
2024
Q4 | $6.48M | Buy |
576,200
+326,200
| +130% | +$3.67M | 0.06% | 427 |
|
|
2024
Q3 | $7.07M | Buy |
+250,000
| New | +$7.07M | 0.06% | 407 |
|
|
2021
Q4 | – | Sell |
-310,036
| Closed | -$9.61M | – | 979 |
|
|
2021
Q3 | $9.61M | Sell |
310,036
-105,775
| -25% | -$3.28M | 0.07% | 423 |
|
|
2021
Q2 | $8.78M | Sell |
415,811
-57,500
| -12% | -$1.21M | 0.06% | 460 |
|
|
2021
Q1 | $9.56M | Sell |
473,311
-94,000
| -17% | -$1.9M | 0.06% | 456 |
|
|
2020
Q4 | $9.09M | Sell |
567,311
-91,000
| -14% | -$1.46M | 0.08% | 397 |
|
|
2020
Q3 | $8.17M | Sell |
658,311
-67,500
| -9% | -$838K | 0.09% | 339 |
|
|
2020
Q2 | $5.17M | Buy |
725,811
+192,400
| +36% | +$1.37M | 0.06% | 447 |
|
|
2020
Q1 | $2.9M | Buy |
533,411
+62,000
| +13% | +$337K | 0.04% | 509 |
|
|
2019
Q4 | $4.27M | Sell |
471,411
-521,000
| -52% | -$4.71M | 0.04% | 529 |
|
|
2019
Q3 | $7.14M | Buy |
992,411
+265,811
| +37% | +$1.91M | 0.07% | 389 |
|
|
2019
Q2 | $5.78M | Buy |
726,600
+305,000
| +72% | +$2.42M | 0.05% | 458 |
|
|
2019
Q1 | $5.3M | Buy |
421,600
+315,600
| +298% | +$3.97M | 0.04% | 494 |
|
|
2018
Q4 | $2.12M | Buy |
+106,000
| New | +$2.12M | 0.02% | 716 |
|